Literature DB >> 19870633

THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS.

M Theiler1, H H Smith.   

Abstract

1. Experimental evidence is presented to show that prolonged cultivation of yellow fever virus in vitro results in a change in its pathogenicity, and that this change varies with the type of tissues used for the cultivation. 2. In the tissue cultures used for the propagation of the virus, three different types of tissues were used. They included whole mouse embryo, chick embryo from which the head and spinal cord had been removed, and testicular tissues of mice and guinea pigs. 3. The changes in the pathogenicity of the virus cultivated for a period of over 3 years in a medium containing the tissues of whole mouse embryo were not striking. The viscerotropic virulence of the virus appeared somewhat diminished, in that when injected subcutaneously into rhesus monkeys or hedgehogs it failed to produce a fatal infection, although there is evidence to indicate that a generalized infection takes place as demonstrated by the appearance of virus in the circulating blood in relatively high concentration during infection. The neurotropic virulence of the virus remained unaltered during the cultivation in this medium. 4. The changes in the pathogenicity of the virus cultivated in medium containing tissues of chick embryo from which the head and spinal cord had been removed were very pronounced. The viscerotropic virulence of the virus was lost to a large extent. When injected subcutaneously into monkeys there was as a rule a very mild generalized infection, as demonstrated by the minimal quantities of virus found in the circulating blood. Its neurotropism was also much diminished. When injected into monkeys intracerebrally, it no longer produced a fatal encephalitis but only a moderate febrile reaction, followed by recovery and solid immunity to reinoculation with a highly virulent strain of virus. When injected intracerebrally into mice, the mortality ratio was not diminished but the incubation period was markedly prolonged. 5. The changes in the pathogenicity of the virus cultivated in medium containing testicular tissues were somewhat similar to those observed after cultivation in chick embryo medium which contained only a minimal amount of nervous tissue. Its viscerotropic affinity had been largely lost and only very small amounts of virus were found in the circulating blood of monkeys inoculated subcutaneously. Given intracerebrally, it produced death from encephalitis in monkeys. The incubation period in mice inoculated intracerebrally with this virus was also prolonged but somewhat less so than with the virus grown in chick embryo tissues without the central nervous system.

Entities:  

Year:  1937        PMID: 19870633      PMCID: PMC2133530          DOI: 10.1084/jem.65.6.767

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  The Behavior of the Virus of Yellow Fever in Monkeys and Mice.

Authors:  A W Sellards
Journal:  Proc Natl Acad Sci U S A       Date:  1931-06       Impact factor: 11.205

2.  CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

Authors:  T M Rivers
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

3.  THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION.

Authors:  M Theiler; H H Smith
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

4.  VACCINATION AGAINST YELLOW FEVER WITH IMMUNE SERUM AND VIRUS FIXED FOR MICE.

Authors:  W A Sawyer; S F Kitchen; W Lloyd
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

5.  FURTHER OBSERVATIONS ON THE CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

Authors:  T M Rivers; S M Ward
Journal:  J Exp Med       Date:  1933-10-31       Impact factor: 14.307

  5 in total
  58 in total

1.  [Cultivation of yellow fever virus in human explants].

Authors:  C HALLAUER
Journal:  Arch Gesamte Virusforsch       Date:  1959

2.  [Further studies on cultivation and variants of the classical fowl plague virus in human tissue explants].

Authors:  C HALLAUER; G KRONAUER
Journal:  Arch Gesamte Virusforsch       Date:  1959

3.  [Research on epidemic meningitis virus (ECHO virus 9)].

Authors:  W HENNESSEN
Journal:  Z Hyg Infektionskr       Date:  1957

Review 4.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.

Authors:  Bali Pulendran
Journal:  Nat Rev Immunol       Date:  2009-09-18       Impact factor: 53.106

5.  Active immunization against poliomyelitis. April 2, 1953.

Authors:  H R Cox
Journal:  J Urban Health       Date:  1998-09       Impact factor: 3.671

6.  History of vaccination.

Authors:  Stanley Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

7.  The yellow fever vaccine: a history.

Authors:  J Gordon Frierson
Journal:  Yale J Biol Med       Date:  2010-06

8.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

9.  Pathogenicity for suckling mice of Coxsackie viruses adapted to human amnion cells.

Authors:  F LEHMANN-GRUBE; J T SYVERTON
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

10.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.